LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Journal Article > Research

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India

Isaakidis P, Varghese B, Mansoor H, Cox HS, Ladomirska J, Saranchuk P, Da Silva E, Paryani R, Udwadia ZF, Migliori GB, Sotgiu G, Reid AJ
Download
Download
Abstract
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB). However, there is little prospective data on AE in MDR- or XDR-TB/HIV co-infected patients on antituberculosis and antiretroviral therapy (ART) in programmatic settings.
Countries
India
Subject Area
antibiotic resistancetuberculosisantimicrobial resistanceHIV/AIDS
DOI
10.1371/journal.pone.0040781
Published Date
11-Jul-2011
PubMed ID
22792406
Languages
English
Journal
PLOS One
Volume / Issue / Pages
Volume 7, Issue 7
Issue Date
11-Jul-2012
Dimensions Badge